# Quest Diagnostics Incorporated (DGX) stock price

URL: https://funkfolio.com/stock/DGX

> Quest Diagnostics Incorporated (DGX) trades at $256.35, is worth $28.2B, is priced at 25.5× earnings and scores 38/100. Valuation, financials and signals.

---

## Quest Diagnostics Incorporated (DGX)

Quest Diagnostics Incorporated (DGX) is a healthcare company (diagnostics & research) based in the United States. The share price is $256.35, down 2.23% on the day, which values the company at $28.2B. Price as of 17 Nov 2026, 21:40 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $256.35 −2.23% today
- **Market value:** $28.2B
- **P/E ratio:** 25.5× last 12 months
- **Forward P/E:** 21.4×
- **Dividend yield:** 1.29%
- **Funk Score:** 38/100
- **Against its own history:** Well above its usual price usual price $165.78
- **200-week average:** $165.91 55% above

Figures as of 17 Nov 2026, 21:40 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Quest Diagnostics Incorporated in more detail

DGX trades at 25.5× its last twelve months' earnings, 21.4× next year's expected earnings, 2.4× sales. Measured against its own history, the price is 55% above what its usual multiples would imply ($165.78) — well above its usual price. It sits 55% above its 200-week average of $165.91.

Over the last five fiscal years Quest Diagnostics Incorporated has compounded revenue 3.2% a year, earnings per share -3.5% a year, free cash flow -3.1% a year. Its Funk Score is 38 out of 100 (financial strength 4.9, profitability 4.7, growth 2.3, value 3.1, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

3 of the superinvestors tracked here hold DGX, including Christopher Davis (1.3% of the portfolio), Jeremy Grantham (co-founder) (1.0% of the portfolio), Pat English (0.9% of the portfolio).

### Superinvestors holding DGX

3 of the investors tracked here report a position in their latest 13F filing.

- [Christopher Davis Davis Advisors](https://funkfolio.com/gurus/christopher-davis) 1.34% of portfolio · $309M · trimmed · Q3 2026
- [Jeremy Grantham (co-founder) GMO (Grantham, Mayo, Van Otterloo)](https://funkfolio.com/gurus/jeremy-grantham) 0.97% of portfolio · $449.9M · added · Q3 2026
- [Pat English Fiduciary Management (FMI)](https://funkfolio.com/gurus/pat-english) 0.91% of portfolio · $59.8M · trimmed · Q3 2026

### Health Care companies of similar size

- [Genmab GMAB](https://funkfolio.com/stock/GMAB)
- [Illumina ILMN](https://funkfolio.com/stock/ILMN)
- [ResMed RMD](https://funkfolio.com/stock/RMD)
- [Zoetis ZTS](https://funkfolio.com/stock/ZTS)
- [Labcorp Holdings LH](https://funkfolio.com/stock/LH)
- [DexCom DXCM](https://funkfolio.com/stock/DXCM)
- [Koninklijke Philips PHG](https://funkfolio.com/stock/PHG)
- [Roivant Sciences ROIV](https://funkfolio.com/stock/ROIV)
- [West Pharmaceutical Services WST](https://funkfolio.com/stock/WST)
- [STERIS STE](https://funkfolio.com/stock/STE)
- [Insmed INSM](https://funkfolio.com/stock/INSM)
- [United Therapeutics UTHR](https://funkfolio.com/stock/UTHR)

Side by side: [DGX vs WST (Quest Diagnostics Incorporated vs West Pharmaceutical Services)](https://funkfolio.com/compare/dgx-vs-wst) [DGX vs ROIV (Quest Diagnostics Incorporated vs Roivant Sciences)](https://funkfolio.com/compare/dgx-vs-roiv) [DGX vs PHG (Quest Diagnostics Incorporated vs Koninklijke Philips)](https://funkfolio.com/compare/dgx-vs-phg) [DGX vs DXCM (Quest Diagnostics Incorporated vs DexCom)](https://funkfolio.com/compare/dgx-vs-dxcm) [DGX vs LH (Quest Diagnostics Incorporated vs Labcorp Holdings)](https://funkfolio.com/compare/dgx-vs-lh)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Quest Diagnostics Incorporated (DGX): questions and answers

**What is DGX's P/E ratio?**

Quest Diagnostics Incorporated trades at 25.5× its last twelve months' earnings and 21.4× next year's expected earnings. At its fiscal year-ends over the past 19 years the P/E ranged from 9.7× to 30.4×, with a median of 17.5×.

**What is DGX's PEG ratio?**

Quest Diagnostics Incorporated's PEG ratio is 1.70 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Quest Diagnostics Incorporated's market cap?**

Quest Diagnostics Incorporated is valued at $28.2B at a share price of $256.35.

**Is DGX overvalued or undervalued?**

Against its own history, DGX is well above its usual price: the price is 55% above the $165.78 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is DGX above its 200-week moving average?**

Yes. DGX is 54.5% above its 200-week average of $165.91. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Quest Diagnostics Incorporated growing?**

Over the last five fiscal years Quest Diagnostics Incorporated's revenue grew 3.2% a year and its earnings per share -3.5% a year; over ten years revenue grew 3.9% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Quest Diagnostics Incorporated (DGX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/DGX

Underlying data: Yahoo Finance; company filings with the SEC.
